当前位置:
X-MOL 学术
›
Liver Cancer
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion
Liver Cancer ( IF 11.6 ) Pub Date : 2021-10-12 , DOI: 10.1159/000519749 Masatoshi Kudo 1
Liver Cancer
中文翻译:
不适合 TACE 的中期 HCC 患者的新治疗策略:先行全身治疗,然后治愈转换
肝癌
更新日期:2021-10-12
Liver Cancer ( IF 11.6 ) Pub Date : 2021-10-12 , DOI: 10.1159/000519749 Masatoshi Kudo 1
Affiliation
Liver Cancer
中文翻译:
不适合 TACE 的中期 HCC 患者的新治疗策略:先行全身治疗,然后治愈转换
肝癌